EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Tranexamic Acid in Breast Surgery – A Systematic Review and Meta-Analysis

Ali Raed Buheiri, Louise Tveskov, Laura Marie Dines, Josephine Dissing Bagge, Sören Möller, Camilla Bille

Clinical Breast Cancer · 2025-07 · 25 (5) · e496-e510

DOI: 10.1016/j.clbc.2025.01.011 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Breast Cancer, 2025-07. Verfasst von Ali Raed Buheiri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark. Electronic address: Ali.…. Hauptthemen laut MEDLINE: Tranexamic Acid, Breast Neoplasms, Antifibrinolytic Agents, Hematoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hematoma formation is a possible postoperative occurrence following breast surgery. It might increase the risk of long-term complications and thereby delay start of adjuvant therapy. Tranexamic acid (TXA) is suggested to decrease the risk of postoperative hematoma, but the evidence is based on small and heterogeneous studies. The primary objective of this systematic review and meta-analysis is to assess the impact of TXA on hematoma formation and secondarily on drain output, time upon drain removal, seroma formation, infection incidents, and thromboembolic events. METHODS: A literature search was conducted in PubMed, Embase, Medline, Cochrane Library, and Google Scholar. Studies examining either intravenous or topically administered TXA were included and underwent risk of bias assessment. RESULTS: A total of 989 studies were screened and 19 studies fulfilled the inclusion criteria. Of the 7673 breasts in total, topical TXA was given to 2106 breasts, intravenous to 1722 and the remaining 4347 breasts were controls having no TXA. Hematoma formation was significantly reduced by both topical administered TXA (RR, 0.33; 95% CI, 0.15-0.75) and intravenous TXA (RR, 0.45; 95% CI, 0.29-0.68) across all breast procedures. The same result was found when only including oncological breast procedures; topical TXA (RR, 0.16; 95% CI, 0.05-0.56) and intravenous TXA (RR, 0.50; 95% CI, 0.31-0.81). A reduction in drain output and time until drain removal was noted. No significant reduction in seroma formation was observed. CONCLUSION: Both topical and intravenous TXA in breast surgery significantly reduce hematoma and reduce drain output and time upon drain removal. Studies show no effect on seroma formation, infection rates, or thromboembolic events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidBreast NeoplasmsAntifibrinolytic AgentsHematomaMastectomyPostoperative ComplicationsHumansFemaleSeromaDrainageAdministration, Topical

Stichwörter der Autor:innen

Drain outputHematomaIntravenousTopical

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Plastic Surgery, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark. Electronic address: Ali.Raed.Buheiri@rsyd.dk.
  • Department of Plastic Surgery, Odense University Hospital, Odense, Denmark. Electronic address: Louise.Tveskov@rsyd.dk.
  • Department of Plastic Surgery, Odense University Hospital, Odense, Denmark.
  • Department of Vascular Surgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • OPEN Patient Data Explorative Network, Odense University Hospital and Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Plastic Surgery, Odense University Hospital, Odense, Denmark; University of Southern Denmark, Odense, Denmark.

Zitieren

APA

Buheiri, A. R., Tveskov, L., Dines, L. M., Bagge, J. D., Möller, S., & Bille, C. (2025). Tranexamic Acid in Breast Surgery – A Systematic Review and Meta-Analysis. Clinical Breast Cancer, 25(5), e496-e510. https://doi.org/10.1016/j.clbc.2025.01.011

Vancouver

Buheiri AR, Tveskov L, Dines LM, Bagge JD, Möller S, Bille C. Tranexamic Acid in Breast Surgery – A Systematic Review and Meta-Analysis. Clinical Breast Cancer. 2025;25(5):e496-e510. doi:10.1016/j.clbc.2025.01.011

BibTeX
@article{Buheiri2025,
  author = {Buheiri, Ali Raed and Tveskov, Louise and Dines, Laura Marie and Bagge, Josephine Dissing and Möller, Sören and Bille, Camilla},
  title = {Tranexamic Acid in Breast Surgery – A Systematic Review and Meta-Analysis},
  journal = {Clinical Breast Cancer},
  year = {2025},
  volume = {25},
  number = {5},
  pages = {e496--e510},
  doi = {10.1016/j.clbc.2025.01.011}
}
Kostenlos starten →